A joint report titled “Clinical Trial Opportunities in India” Report was released recently by the PwC India and US-India Chamber of Commerce (USAIC). Key findings of the Report:...
The US Food and Drug Administration (FDA) has approved lecanemab, a monoclonal antibody developed by Eisai and Biogen, for the treatment of Alzheimer’s disease. Lecanemab is the second...
The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are...
The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to use Alhydroxiquim-II to boost the immune system. Highlights COVAXIN has...
On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first COVID-19 vaccine by August 15. Highlights There are 12 institutes...
Health and Family Welfare Ministry have issued the Drugs and Clinical Trials Rules, 2019 with a motive to enhance clinical research in the country. The new rules will...
As per the data of the Drug Controller-General of India, India recorded 2061 drug trial-related deaths during the period (January 2008- January 2012). Maharashtra registered maximum number of...
A regulatory mechanism in Biodiversity sector to be in place following the recommendations Objective: To safeguard public health and protect environment. Quality Control lab in Delhi has been...
